These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16428929)

  • 1. Src tyrosine kinase as a chemotherapeutic target: is there a clinical case?
    Chen T; George JA; Taylor CC
    Anticancer Drugs; 2006 Feb; 17(2):123-31. PubMed ID: 16428929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src kinase inhibitors: promising cancer therapeutics?
    Creedon H; Brunton VG
    Crit Rev Oncog; 2012; 17(2):145-59. PubMed ID: 22471705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel patented SRC kinase inhibitor.
    Lu XL; Liu XY; Cao X; Jiao BH
    Curr Med Chem; 2012; 19(12):1821-9. PubMed ID: 22414081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRC inhibitors as potential therapeutic agents for human cancers.
    Trevino JG; Summy JM; Gallick GE
    Mini Rev Med Chem; 2006 Jun; 6(6):681-7. PubMed ID: 16787379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of Src family kinases and therapeutic implications of their modulators.
    Kumar A; Jaggi AS; Singh N
    Fundam Clin Pharmacol; 2015 Apr; 29(2):115-30. PubMed ID: 25545125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Src family kinases in anti-cancer therapies: turning promise into triumph.
    Zhang S; Yu D
    Trends Pharmacol Sci; 2012 Mar; 33(3):122-8. PubMed ID: 22153719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of Src expression and activity in human neoplasia.
    Chatzizacharias NA; Kouraklis GP; Giaginis CT; Theocharis SE
    Histol Histopathol; 2012 Jun; 27(6):677-92. PubMed ID: 22473690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src inhibitors in breast cancer therapy.
    Hiscox S; Nicholson RI
    Expert Opin Ther Targets; 2008 Jun; 12(6):757-67. PubMed ID: 18479222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Src signaling pathway: a potential target in melanoma and other malignancies.
    Homsi J; Cubitt C; Daud A
    Expert Opin Ther Targets; 2007 Jan; 11(1):91-100. PubMed ID: 17150037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors.
    Park SI; Shah AN; Zhang J; Gallick GE
    Expert Opin Ther Targets; 2007 Sep; 11(9):1207-17. PubMed ID: 17845146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of targeted interference with Src-mediated signal transduction events.
    Ly QP; Yeatman TJ
    Recent Results Cancer Res; 2007; 172():169-88. PubMed ID: 17607941
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of Src in solid tumors.
    Wheeler DL; Iida M; Dunn EF
    Oncologist; 2009 Jul; 14(7):667-78. PubMed ID: 19581523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
    Montero JC; Seoane S; Ocaña A; Pandiella A
    Clin Cancer Res; 2011 Sep; 17(17):5546-52. PubMed ID: 21670084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Src in breast cancer.
    Finn RS
    Ann Oncol; 2008 Aug; 19(8):1379-1386. PubMed ID: 18487549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRC: a century of science brought to the clinic.
    Aleshin A; Finn RS
    Neoplasia; 2010 Aug; 12(8):599-607. PubMed ID: 20689754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.
    Kim MP; Park SI; Kopetz S; Gallick GE
    Cell Tissue Res; 2009 Jan; 335(1):249-59. PubMed ID: 18815812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRC kinase inhibitors: an update on patented compounds.
    Schenone S; Brullo C; Musumeci F; Radi M; Castagnolo D
    Curr Med Chem; 2011; 18(33):5061-78. PubMed ID: 22050754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src kinase and pancreatic cancer.
    Hilbig A
    Recent Results Cancer Res; 2008; 177():179-85. PubMed ID: 18084959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src inhibitors in lung cancer: current status and future directions.
    Rothschild SI; Gautschi O; Haura EB; Johnson FM
    Clin Lung Cancer; 2010 Jul; 11(4):238-42. PubMed ID: 20630825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Apr; 94():9-25. PubMed ID: 25662515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.